- NEWS FEATURE
How protein-slayer drugs could beat some of the cruellest cancers
Illustration: Agnes Jonas
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 641, 300-302 (2025)
doi: https://doi.org/10.1038/d41586-025-01350-2
References
Hont, A. B. & Bollard, C. M. Cold Spring Harb. Perspect. Med. https://doi.org/ 10.1101/cshperspect.a041636 (2025).
Sakamoto, K. M. et al. Proc. Natl Acad. Sci. USA 98, 8554–8559 (2001).
Bondeson, D. P. et al. Nature Chem. Biol. 11, 611–617 (2015).
Zengerle, M., Chan, K.-H. & Ciulli, A. ACS Chem. Biol. 10, 1770–1777 (2015).
Winter, G. E. et al. Science 348, 1376–1381 (2015).
Takeda, K. et al. Nature 380, 627–630 (1996).
‘Dark proteins’ hiding in our cells could hold clues to cancer and other diseases
This scientist treated her own cancer with viruses she grew in the lab
How engineers and drug developers are working to change childhood cancer’s deadly calculus